Dalia S. Saif
Shebin El Kom, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Efficacy of Paroxetine as an Adjuvant Therapy in Rheumatoid Arthritis Patients: A Randomized Controlled Study.
Journal: Drug design, development and therapy
Published: October 08, 2025
The diagnostic value of ultrasonographic vein wall thickness measurement in patients with Behçet's disease.
Journal: Journal of rheumatic diseases
Published: February 03, 2025
Anti-mutated citrullinated vimentin antibodies as a biomarker for interstitial lung disease in patients with rheumatoid arthritis.
Journal: ARP rheumatology
Published: January 04, 2025
The correlation between retinal microvascular changes by optical coherence tomography angiography and nailfold capillaroscopic findings in patients with systemic sclerosis.
Journal: Journal of rheumatic diseases
Published: October 23, 2024
Deciphering the role of Wnt/β-catenin and miR-214 in knee osteoarthritis: molecular and clinical insights.
Journal: Frontiers in pharmacology
Published: October 08, 2024
14-3-3 Eta protein as a novel biomarker in early detection of uveitis in Egyptian juvenile idiopathic arthritis and rheumatoid arthritis patients: Diagnostic and prognostic value.
Journal: Rheumatology and immunology research
Published: July 12, 2024
The Frequency of Musculoskeletal Disorders and Nerve Entrapment Syndromes Around the Shoulder in a Cohort of Egyptian Patients.
Journal: Current rheumatology reviews
Published: July 07, 2024
Efficacy of the cardiac glycoside digoxin as an adjunct to csDMARDs in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled trial.
Journal: Frontiers in pharmacology
Published: June 07, 2024
Response to letter to editor.
Journal: International journal of rheumatic diseases
Published: November 15, 2022
Prevalence of peripheral neuropathy and myopathy in patients post-COVID-19 infection.
Journal: International journal of rheumatic diseases
Published: February 20, 2022
The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: A proof-of-concept, randomized, double-blind, placebo-controlled trial.
Journal: International immunopharmacology
Published: January 21, 2021
Last Updated: 09/26/2026